Co-Diagnostics Inc.

NASDAQ: CODX · Real-Time Price · USD
0.30
-0.00 (-0.03%)
At close: Jun 09, 2025, 3:59 PM

Co-Diagnostics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
2.94M 14.92M 22.97M 88.61M
Short-Term Investments
26.81M 43.63M 58.29M 1.26M
Long-Term Investments
731.07K 773.38K 672.68K 1M
Other Long-Term Assets
n/a n/a 672.68K -484.92K
Receivables
132.57K 330.88K 5.4M 20.91M
Inventory
1.07M 1.66M 5.31M 2M
Other Current Assets
1.34M 1.6M n/a n/a
Total Current Assets
32.29M 62.14M 92.73M 115.12M
Property-Plant & Equipment
4.88M 6M 2.91M 1.93M
Goodwill & Intangibles
26.1M 26.4M 26.77M 41.9M
Total Long-Term Assets
31.71M 33.18M 30.35M 44.91M
Total Assets
64M 95.32M 123.09M 160.03M
Account Payables
3.29M 1.48M 952.3K 607.51K
Deferred Revenue
40.86K 362.45K n/a 150K
Short-Term Debt
915.62K 529.77K 297.21K n/a
Other Current Liabilities
502.82K 1.42M 1.9M 7.17M
Total Current Liabilities
7.32M 5.75M 3.87M 12.6M
Long-Term Debt
1.24M n/a n/a n/a
Other Long-Term Liabilities
1.14M 1.41M 2.22M 5.73M
Total Long-Term Liabilities
1.24M 3.56M 4.69M 12.96M
Total Liabilities
9.69M 9.31M 8.57M 25.56M
Total Debt
2.15M 2.99M 347.92K n/a
Common Stock
37.9K 36.11K 34.75K 33.82K
Retained Earnings
-33.04M 4.6M 39.93M 54.17M
Comprehensive Income
418.44K 146.7K 293.14K 0.00
Shareholders Equity
54.31M 86.01M 114.52M 134.48M
Total Investments
27.54M 44.4M 58.96M 2.26M